Orum Therapeutics USA, Inc.
1 clinical trials · Sponsor
◉ Watch Orum Therapeutics USA, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors (NCT05511844) | Orum Therapeutics USA, Inc. | 2022-10-03 |
Track Orum Therapeutics USA, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.